Company Filing History:

12 out of 2,538

Warner-Lambert Company

patents

British Technology Group Limited

where one patent can have more than one assignee

Years Active: 1987-2011

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7863278 - Isethionate salt of a selective CDK4 inhibitor (2011-01-04),

2. 7655656 - Hair growth promoting agents (2010-02-02),

3. 6960662 - Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones (2005-11-01),

4. 5659048 - Chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and (1997-08-19),

5. 5481000 - Process for preparing chiral (1996-01-02),

6. 5449778 - Cyclic amino acids and derivatives thereof (1995-09-12),

7. 5380925 - Cyclic amino acids and derivatives thereof (1995-01-10),

8. 5342959 - Process for preparing chiral (1994-08-30),

9. 5264577 - Cyclic amino acids and derivatives thereof (1993-11-23),

10. 5198548 - Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and (1993-03-30),

11. 4806654 - Processes for the preparation of benzo(chalcogeno)(4,3,2-cd)indazoles (1989-02-21),

12. 4689423 - Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates (1987-08-25),

13. 4672129 - Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones (1987-06-09),

Title: Vladimir Genukh Beylin: Innovator in Pharmaceutical Patents

Introduction

Vladimir Genukh Beylin is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on developing innovative compounds that address critical health issues.

Latest Patents

Among his latest patents is the isethionate salt of a selective CDK4 inhibitor. This invention discloses polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which serves as a selective cyclin-dependent kinase 4 (CDK4) inhibitor. This compound is particularly useful for treating inflammation and cell proliferative diseases such as cancer and restenosis. Another notable patent involves hair growth promoting agents, which are directed to crystalline forms of 6-[[[3S,4R)-3,4-dihydro-3-hydroxy-6-[(3-hydroxypheny)sulfonyl]-2,2,3-trimethyl-2H-1-benzopyran-4-yl]oxy]-2-methyl-3(2H)-pyridazinone. This invention includes formulations containing these crystalline forms and their application in promoting hair growth.

Career Highlights

Vladimir has worked with several notable companies throughout his career, including Warner-Lambert Company and British Tech Group. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Vladimir has collaborated with esteemed colleagues such as Om Prakash Goel and Huai G Chen. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Vladimir Genukh Beylin is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in health-related innovations. His contributions through various patents demonstrate his commitment to improving medical treatments and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent pending (CIPO):

Please report any incorrect information to support@idiyas.com